Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 30, 2019
Does CSF pleocytosis have a predictive value for disease course in MS?
Itay Lotan, Felix Benninger, Rom Mendel, et al.
Journal of Neuroimmunology
|
September 30, 2018
Recurrent optic neuritis - Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease
Itay Lotan, Mark A Hellmann, Felix Benninger, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
June 28, 2016
Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome
Judith Brody, Mark A Hellmann, Romain Marignier, et al.
Journal of Neurology
|
July 9, 2025
Familial myasthenia gravis: characterization of an Israeli cohort and systematic review of the literature
Mark A Hellmann, Israel Steiner, Maor Mermelstein, et al.
Acta Neurologica Scandinavica
|
March 8, 2020
Incidence of AChR Ab-positive myasthenia gravis in Israel: A population-based study
Itay Lotan, Felix Benninger, Mark A Hellmann, et al.
Neuromuscular Disorders : NMD
|
March 1, 2022
Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis
Itay Lotan, Mark A Hellmann, Yitzhak Friedman, et al.
European Journal of Neurology
|
July 21, 2021
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
Itay Lotan, Adi Wilf-Yarkoni, Yitzhak Friedman, et al.
European Journal of Neurology
|
March 19, 2026
Risk of New-Onset Myasthenia Gravis Following COVID-19 Infection and Vaccination: A Population-Based Case-Control Study
Tasneem Kab, Keshet Pardo, Mark A Hellmann, et al.
Frontiers in Immunology
|
April 18, 2022
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses
Ron Milo, Elsebeth Staun-Ram, Dimitrios Karussis, et al.
The Israel Medical Association Journal : IMAJ
|
July 31, 2024
Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli Cohort
Aviv Fineberg, Itay Lotan, Omer Bialer, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 30, 2019
Does CSF pleocytosis have a predictive value for disease course in MS?
Itay Lotan, Felix Benninger, Rom Mendel, et al.
Journal of Neuroimmunology
|
September 30, 2018
Recurrent optic neuritis - Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease
Itay Lotan, Mark A Hellmann, Felix Benninger, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
June 28, 2016
Neuromyelitis Optica Spectrum Disorder: Disease Course and Long-Term Visual Outcome
Judith Brody, Mark A Hellmann, Romain Marignier, et al.
Journal of Neurology
|
July 9, 2025
Familial myasthenia gravis: characterization of an Israeli cohort and systematic review of the literature
Mark A Hellmann, Israel Steiner, Maor Mermelstein, et al.
Acta Neurologica Scandinavica
|
March 8, 2020
Incidence of AChR Ab-positive myasthenia gravis in Israel: A population-based study
Itay Lotan, Felix Benninger, Mark A Hellmann, et al.
Neuromuscular Disorders : NMD
|
March 1, 2022
Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis
Itay Lotan, Mark A Hellmann, Yitzhak Friedman, et al.
European Journal of Neurology
|
July 21, 2021
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
Itay Lotan, Adi Wilf-Yarkoni, Yitzhak Friedman, et al.
European Journal of Neurology
|
March 19, 2026
Risk of New-Onset Myasthenia Gravis Following COVID-19 Infection and Vaccination: A Population-Based Case-Control Study
Tasneem Kab, Keshet Pardo, Mark A Hellmann, et al.
Frontiers in Immunology
|
April 18, 2022
Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses
Ron Milo, Elsebeth Staun-Ram, Dimitrios Karussis, et al.
The Israel Medical Association Journal : IMAJ
|
July 31, 2024
Applicability of the New Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Diagnostic Criteria in an Israeli Cohort
Aviv Fineberg, Itay Lotan, Omer Bialer, et al.
Page
of 4